Key Details
Price
$18.69Annual ROE
49.91%Beta
1.60Events Calendar
Next earnings date:
Mar 12, 2025Recent quarterly earnings:
Nov 7, 2024Recent annual earnings:
Mar 7, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Apr 5, 2024Analyst ratings
Recent major analysts updates
Jan 28, 25 HC Wainwright & Co.
BuyJan 27, 25 Needham
BuyJan 13, 25 Needham
BuyDec 19, 24 BTIG
BuyDec 4, 24 HC Wainwright & Co.
BuyDec 3, 24 Needham
BuyNov 25, 24 Needham
BuyNov 8, 24 Needham
BuyNov 8, 24 HC Wainwright & Co.
BuyOct 16, 24 Needham
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Cartesian Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Cartesian Therapeutics?
- Does Cartesian Therapeutics pay dividends?
- What sector is Cartesian Therapeutics in?
- What industry is Cartesian Therapeutics in?
- What country is Cartesian Therapeutics based in?
- When did Cartesian Therapeutics go public?
- Is Cartesian Therapeutics in the S&P 500?
- Is Cartesian Therapeutics in the NASDAQ 100?
- Is Cartesian Therapeutics in the Dow Jones?
- When was Cartesian Therapeutics's last earnings report?
- When does Cartesian Therapeutics report earnings?
- Should I buy Cartesian Therapeutics stock now?
What is the ticker symbol for Cartesian Therapeutics?
The ticker symbol for Cartesian Therapeutics is NASDAQ:RNAC
Does Cartesian Therapeutics pay dividends?
No, Cartesian Therapeutics does not pay dividends
What sector is Cartesian Therapeutics in?
Cartesian Therapeutics is in the Healthcare sector
What industry is Cartesian Therapeutics in?
Cartesian Therapeutics is in the Biotechnology industry
What country is Cartesian Therapeutics based in?
Cartesian Therapeutics is headquartered in United States
When did Cartesian Therapeutics go public?
Cartesian Therapeutics's initial public offering (IPO) was on June 22, 2016
Is Cartesian Therapeutics in the S&P 500?
No, Cartesian Therapeutics is not included in the S&P 500 index
Is Cartesian Therapeutics in the NASDAQ 100?
No, Cartesian Therapeutics is not included in the NASDAQ 100 index
Is Cartesian Therapeutics in the Dow Jones?
No, Cartesian Therapeutics is not included in the Dow Jones index
When was Cartesian Therapeutics's last earnings report?
Cartesian Therapeutics's most recent earnings report was on Nov 7, 2024
When does Cartesian Therapeutics report earnings?
The next expected earnings date for Cartesian Therapeutics is Mar 12, 2025
Should I buy Cartesian Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions